Immunomodulatory effects of IFNβ-1b on the mRNA-expression of TGFβ-1 and TNFα in vitro

Immunopharmacology

Volumn 43, Issue 1, 1999, Pages 39-46

  Ossege, L M ^a   Sindern, E ^a   Voss, B ^b   Malin, J P ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

Cytokine expression; Immunomodulatory therapy; Interferon beta 1b; Multiple sclerosis; Transforming growth factor beta 1; Tumor necrosis factor alpha

Indexed keywords

INTERFERON BETA SERINE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; BETA INTERFERON; IMMUNOLOGICAL ADJUVANT; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; MALE; MULTIPLE SCLEROSIS; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; DOSE RESPONSE; DRUG EFFECT; GENETICS; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE; METABOLISM; MIDDLE AGED;

ADJUVANTS, IMMUNOLOGIC; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; HUMANS; INTERFERON-BETA; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032587538     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00038-7     Document Type: Article

References (42)

1. Abu Kahbar K.S., Armstrong J.A., Ho M. Type I interferons (IFN-alpha and -beta) suppress cytotoxin (tumor necrosis factor-alpha and lymphotoxin) production by mitogen-stimulated human peripheral blood mononuclear cells. J. Leukocyte Biol. 52:1992;165-172.
2. Balkwill F.R. Interferons. Lancet. 1:1989;1060-1063.
3. Brod S.A., Marshall G.D., Henninger B.A., Sriram S., Khan B.S., Wolinsky J.S. Interferon-β-1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis. Neurology. 46:1996;1633-1638.
4. Denhardt D.T. A membrane filter technique for detection of complementary DNA. Biochem. Biophys. Res. Commun. 23:1966;641-646.
5. Dixit V.M., Green S., Sarma V., Holzmann L.B., Wolf F.W., O'Rourke K., Ward P.A., Prochownik E.V., Marks R.M. Tumor necrosis factor-α induction of novel gene products in human endothelial cells including a macrophage-specific chemotoxin. J. Biol. Chem. 165:1990;2973-2978.
6. Drissen C., Hirv K., Wellinghausen N., Kirchner H., Rink L. Influence of serum on zinc, toxic shock syndrome toxin-1, and lipopolysaccharide-induced production of IFN-γ and IL-1β by human mononuclear cells. J. Leukocyte Biol. 57:1995;904-908.
7. Dustin M.L., Springer T.A. Lymphocyte-function-associated antigen-1. Interaction with cellular adhesion molecule-1 (ICAM-1) is one of the least three mechanisms for lymphocyte adhesion to culture endothelial cells. J. Cell Biol. 107:1988;321-331.
8. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
9. Hughes C.C.W., Male D.K., Lantos P.L. Adhesion of lymphocytes to cerebral microvascular cells: effects of interferon-γ, tumor necrosis factor and interleukin 1. Immunology. 64:1988;677-681.
10. Jacob C.O. Tumor necrosis factor A in autoimmunity: pretty girl or old witch? Immunol. Today. 13:1992;122-125.
11. Kaushansky K., Broudy V.C., Harlan J.M., Adamson J.W. Tumor-necrosis-factor-α and tumor-necrosis-factor-β (lymphotoxin) stimulate the production of granulocyte macrophage colony-stimulating factor, macrophage-stimulating factor and IL-1 in vivo. J. Immunol. 141:1988;3410-3415.
12. Kekow J., Gross W.L. Transforming growth factor beta: Wirkungsweise und klinische Bedeutung. Dtsch. Med. Wochenschr. 117:1992;228-235.
13. Kohase M., Hendrikson-DeStefano D., May L.T., Vilcek J., Sehgal P.B. Introduction of β2-interferon by tumor necrosis factor: a hemostatic mechanism in the control of cell proliferation. Cell. 45:1986;659-666.
14. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
15. Leppert D., Waubant E., Bürk M.R., Oksenberg J.R., Hauser S.L. Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 40:1996;846-852.
16. Link J., Söderström M., Olsson T., Höjeberg B., Ljingdahl A., Link H. Increased transforming growth factor-β, interleukin-4, and interferon-γ in multiple sclerosis. Ann. Neurol. 36:1994;379-386.
17. Martin R., McFarland H.F., McFarlin D.E. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:1992;153-187.
18. McFarlin D.E., McFarland H.F. Multiple sclerosis. N. Engl. J. Med. 307:1982;1183-1188.
19. Noronha A., Toscas A., Jensen M.A. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis. J. Neuroimmunol. 46:1993;1605-1621.
20. Noronha A., Jensen M., Toscas A. TGF-β activity in MS: effect of IFN-β Neurology. 43:1993;355. Suppl.
21. Ogden, R.C., Adams, D., 1987. Electrophoresis in agarose and acrylamide gels. In: Berger, S.L., Kimmel, A.R. (Eds.), Guide to Molecular Cloning Technique. Methods in Enzymology, Vol. 152. Academic Press, Orlando, pp. 61-87.
22. Old L.J. Tumor necrosis factor. Science. 230:1985;630-632.
23. Olsson T. Role of cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis. Eur. J. Neurol. 1:1994;7-19.
24. Osborne L., Hession C., Tizard R., Vassalo C., Luhowskyi S., Chi-Rosso G., Lobb R. Direct expression cloning of vascular cell adhesion molecule-1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell. 59:1989;1203-1211.
25. Ossege L.M., Voss B., Wiethege T., Sindern E., Malin J.P. Detection of transforming growth factor beta-1 mRNA in cerebrospinal fluid cells in patients with meningitis by non-radioactive in situ hybridization. J. Neurol. 242:1994;14-19.
26. Ossege L.M., Sindern E., Patzold T., Malin J.P. Immunomodulatory effects of interferon-β-1b in vivo: induction of the expression of TGFβ-1 and its receptor type II. J. Neuroimmunol. 91:1998;73-81.
27. Paty, D.W., Li, D.K.B., 1993. Interferon β 1b is effective in relapsing and remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind placebo controlled trail. Neurology 43, 662-667.
28. Porrini A.M., Gambi D., Reder A.T. Interferon effects on interleukin-10 secretion; mononuclear cell response to interleukin-10 is normal in multiple sclerosis. J. Neuroimmunol. 61:1995;27-34.
29. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley A.W., Silberberg D.H., Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231.
30. Ranges G.E., Fiagri I.S., Espevic T., Paladino M.A. Jr. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by tumor necrosis factor alpha. J. Exp. Med. 166:1987;991-998.
31. Rep M.H.G., Hintzen R.Q., Polman C.H., van Lier R.A.W. Recombinant interferon-β blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J. Neuroimmunol. 67:1996;11-118.
32. Rieckmann P., Albrecht M., Kitze B., Weber T., Tumani H., Brooks A., Lüer W., Poser S. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology. 44:1994;1523-1526.
33. Rieckmann P., Albrecht B.A., Kitze B., Weber T., Tumani H., Broocks A., Lüer W., Helwig A., Poser S. Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann. Neurol. 37:1995;82-88.
34. Rook A., Kehrl J.H., Wakefield L.M., Roberts A.B., Sporn M.B., Burlington D.B. Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness. J. Immunol. 136:1986;3916-3920.
35. Rudick R.A., Ransohoff R.M. Cytokine secretion by multiple sclerosis monocytes. Relationship to disease activity. Arch. Neurol. 49:1992;265-270.
36. Satoh J.I., Paty D.W., Kim S.U. Differential effects of beta and gamma interferons on expression of major histocompatibility complex antigens and intercellular adhesion molecule-1 in cultured fetal human astrocytes. Neurology. 45:1995;367-373.
37. Shalaby M.R., Ammann A.J. Suppression of immune cell function in vitro by recombinant human transforming-growth-factor-beta. Cell Immunol. 112:1988;343-350.
38. Streiter R.M., Kunkel S., Showell H.J., Remick D.G., Phan S.H., Ward P.A., Marks R.M. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β Science. 241:1989;1467-1469.
39. Stüve O., Dooley N.P., Uhm J.H., Antel J.P., Francis G.S., Williams G., Yong V.W. Interferon β-1b decreases the migration of T lymphocytes in vitro: effects in matrix metalloproteinase-9. Ann. Neurol. 40:1996;853-863.
40. Sugarman B.J., Lewis G.D., Essalu T.E., Aggarwal B.B., Shepard H.M. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res. 37:1987;780-786.
41. The Interferon β Multiple Sclerosis Study Group Clinical results of a multicenter, randomized, double-blind placebo controlled trail. Neurology. 43:1993;655-661.
42. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature. 334:1988;260-262.